Optimum Investment Advisors Pfizer Inc Transaction History

Optimum Investment Advisors

  • $244 Million
  • Q3 2025

A detailed history of Optimum Investment Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Optimum Investment Advisors holds 20,164 shares of PFE stock, worth $505,713. This represents 0.21% of its overall portfolio holdings.

Number of Shares
20,164
Previous 21,364 5.62%
Holding current value
$505,713
Previous $517,000 0.77%
% of portfolio
0.21%
Previous 0.23%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025
SELL
$23.29 - $25.88 $27,948 - $31,056
-1,200 Reduced 5.62%
20,164 $513,000
Q2 2025

Jul 31, 2025
SELL
$21.59 - $24.84 $16,192 - $18,630
-750 Reduced 3.39%
21,364 $517,000
Q1 2025

Apr 30, 2025
SELL
$25.01 - $27.13 $2,501 - $2,713
-100 Reduced 0.45%
22,114 $560,000
Q3 2024

Oct 16, 2024
BUY
$27.7 - $31.39 $27,700 - $31,390
1,000 Added 4.71%
22,214 $642,000
Q2 2024

Jul 12, 2024
BUY
$25.26 - $29.6 $251,488 - $294,697
9,956 Added 88.43%
21,214 $593,000
Q1 2024

Apr 11, 2024
SELL
$25.89 - $29.73 $80,259 - $92,163
-3,100 Reduced 21.59%
11,258 $312,000
Q4 2023

Jan 08, 2024
SELL
$26.13 - $33.94 $52,991 - $68,830
-2,028 Reduced 12.38%
14,358 $413,000
Q3 2023

Oct 13, 2023
BUY
$32.09 - $37.51 $96 - $112
3 Added 0.02%
16,386 $543,000
Q2 2023

Aug 03, 2023
BUY
$36.12 - $41.79 $69,531 - $80,445
1,925 Added 13.31%
16,383 $600,000
Q1 2023

May 03, 2023
SELL
$39.39 - $51.28 $105,801 - $137,738
-2,686 Reduced 15.67%
14,458 $589,000
Q4 2022

Jan 05, 2023
SELL
$41.75 - $54.5 $61,163 - $79,842
-1,465 Reduced 7.87%
17,144 $0
Q3 2022

Oct 24, 2022
SELL
$43.76 - $53.42 $8,883 - $10,844
-203 Reduced 1.08%
18,609 $814,000
Q2 2022

Jul 12, 2022
SELL
$46.53 - $55.17 $5,211 - $6,179
-112 Reduced 0.59%
18,812 $986,000
Q1 2022

Apr 08, 2022
SELL
$45.75 - $56.69 $60,344 - $74,774
-1,319 Reduced 6.52%
18,924 $980,000
Q4 2021

Mar 17, 2022
SELL
$41.32 - $61.25 $8,264 - $12,250
-200 Reduced 0.98%
20,243 $1.2 Million
Q3 2021

Oct 22, 2021
SELL
$39.25 - $50.42 $120,458 - $154,738
-3,069 Reduced 13.05%
20,443 $879,000
Q2 2021

Aug 02, 2021
SELL
$35.91 - $40.68 $82,592 - $93,564
-2,300 Reduced 8.91%
23,512 $921,000
Q1 2021

Apr 15, 2021
BUY
$33.49 - $37.77 $3,349 - $3,777
100 Added 0.39%
25,812 $935,000
Q4 2020

Jan 21, 2021
BUY
$33.47 - $42.56 $45,184 - $57,456
1,350 Added 5.54%
25,712 $946,000
Q3 2020

Oct 06, 2020
SELL
$31.75 - $37.25 $157,162 - $184,387
-4,950 Reduced 16.89%
24,362 $894,000
Q2 2020

Jul 16, 2020
SELL
$30.12 - $36.54 $28,915 - $35,078
-960 Reduced 3.17%
29,312 $959,000
Q1 2020

Apr 21, 2020
SELL
$27.03 - $38.62 $55,789 - $79,711
-2,064 Reduced 6.38%
30,272 $988,000
Q4 2019

Jan 22, 2020
SELL
$32.92 - $37.36 $20,542 - $23,312
-624 Reduced 1.89%
32,336 $1.27 Million
Q3 2019

Oct 17, 2019
BUY
$32.49 - $42.13 $89,607 - $116,194
2,758 Added 9.13%
32,960 $1.18 Million
Q2 2019

Jul 29, 2019
SELL
$36.98 - $41.52 $1,922 - $2,159
-52 Reduced 0.17%
30,202 $1.31 Million
Q1 2019

May 03, 2019
SELL
$37.5 - $41.2 $20,925 - $22,989
-558 Reduced 1.81%
30,254 $1.29 Million
Q4 2018

Feb 04, 2019
SELL
$38.47 - $43.86 $70,784 - $80,702
-1,840 Reduced 5.64%
30,812 $1.35 Million
Q3 2018

Oct 05, 2018
SELL
$34.47 - $41.81 $26,852 - $32,569
-779 Reduced 2.33%
32,652 $1.44 Million
Q2 2018

Oct 05, 2018
SELL
$32.98 - $35.16 $43,368 - $46,235
-1,315 Reduced 3.78%
33,431 $1.21 Million
Q1 2018

May 09, 2018
BUY
$31.91 - $37.02 $41,674 - $48,348
1,306 Added 3.91%
34,746 $1.23 Million
Q4 2017

Jan 16, 2018
BUY
$33.26 - $35.29 $13,503 - $14,327
406 Added 1.23%
33,440 $1.21 Million
Q3 2017

Nov 21, 2017
BUY
$31.0 - $34.15 $19,096 - $21,036
616 Added 1.9%
33,034 $1.18 Million
Q2 2017

Aug 14, 2017
BUY
N/A
32,418
32,418 $1.09 Million

Others Institutions Holding PFE

# of Institutions
3,354
Shares Held
3.57B
Call Options Held
87.2M
Put Options Held
106M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Optimum Investment Advisors Portfolio

Follow Optimum Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email